CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Value Chain Analysis
3.6. Pricing Analysis
3.7. Key Regulation Analysis
3.8. Patent Landscape
CHAPTER 4: CYCLODEXTRIN MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Alpha-Cyclodextrin
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Beta-Cyclodextrin
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Gamma-Cyclodextrin
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: CYCLODEXTRIN MARKET, BY END-USER INDUSTRY
5.1. Overview
5.1.1. Market size and forecast
5.2. Food
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Pharmaceutical
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Cosmetics and Personal Care
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Chemical
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Textile
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
5.7. Others
5.7.1. Key market trends, growth factors and opportunities
5.7.2. Market size and forecast, by region
5.7.3. Market share analysis by country
CHAPTER 6: CYCLODEXTRIN MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Type
6.2.3. Market size and forecast, by End-User Industry
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Type
6.2.4.1.2. Market size and forecast, by End-User Industry
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Type
6.2.4.2.2. Market size and forecast, by End-User Industry
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Type
6.2.4.3.2. Market size and forecast, by End-User Industry
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Type
6.3.3. Market size and forecast, by End-User Industry
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Type
6.3.4.1.2. Market size and forecast, by End-User Industry
6.3.4.2. UK
6.3.4.2.1. Market size and forecast, by Type
6.3.4.2.2. Market size and forecast, by End-User Industry
6.3.4.3. France
6.3.4.3.1. Market size and forecast, by Type
6.3.4.3.2. Market size and forecast, by End-User Industry
6.3.4.4. Spain
6.3.4.4.1. Market size and forecast, by Type
6.3.4.4.2. Market size and forecast, by End-User Industry
6.3.4.5. Italy
6.3.4.5.1. Market size and forecast, by Type
6.3.4.5.2. Market size and forecast, by End-User Industry
6.3.4.6. Rest of Europe
6.3.4.6.1. Market size and forecast, by Type
6.3.4.6.2. Market size and forecast, by End-User Industry
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Type
6.4.3. Market size and forecast, by End-User Industry
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Market size and forecast, by Type
6.4.4.1.2. Market size and forecast, by End-User Industry
6.4.4.2. India
6.4.4.2.1. Market size and forecast, by Type
6.4.4.2.2. Market size and forecast, by End-User Industry
6.4.4.3. Japan
6.4.4.3.1. Market size and forecast, by Type
6.4.4.3.2. Market size and forecast, by End-User Industry
6.4.4.4. South Korea
6.4.4.4.1. Market size and forecast, by Type
6.4.4.4.2. Market size and forecast, by End-User Industry
6.4.4.5. Australia
6.4.4.5.1. Market size and forecast, by Type
6.4.4.5.2. Market size and forecast, by End-User Industry
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Type
6.4.4.6.2. Market size and forecast, by End-User Industry
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Type
6.5.3. Market size and forecast, by End-User Industry
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Type
6.5.4.1.2. Market size and forecast, by End-User Industry
6.5.4.2. Saudi Arabia
6.5.4.2.1. Market size and forecast, by Type
6.5.4.2.2. Market size and forecast, by End-User Industry
6.5.4.3. South Africa
6.5.4.3.1. Market size and forecast, by Type
6.5.4.3.2. Market size and forecast, by End-User Industry
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Market size and forecast, by Type
6.5.4.4.2. Market size and forecast, by End-User Industry
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Cayman Chemical Company
8.1.1. Company overview
8.1.2. Key executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Cambrex Corporation
8.2.1. Company overview
8.2.2. Key executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Wellona Pharma Private Limited.
8.3.1. Company overview
8.3.2. Key executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Wacker Chemie AG.
8.4.1. Company overview
8.4.2. Key executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Cyclolab
8.5.1. Company overview
8.5.2. Key executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Tocopharm Co. Limited
8.6.1. Company overview
8.6.2. Key executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Roquette Freres
8.7.1. Company overview
8.7.2. Key executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. Midas Pharma GmbH
8.8.1. Company overview
8.8.2. Key executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Ligand Pharmaceuticals Incorporated
8.9.1. Company overview
8.9.2. Key executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Cyclo Therapeutics, Inc
8.10.1. Company overview
8.10.2. Key executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments
| ※参考情報 シクロデキストリンとは、グルコースユニットが環状に結合したオリゴ糖の一種です。主にデンプンを原料とし、特定の酵素によって生成されます。シクロデキストリンは、その独特な構造により、疎水性の分子を包み込む能力があり、これを利用して様々な応用がされています。 シクロデキストリンには主に三種類があります。α-シクロデキストリンは6つのグルコースユニットから構成され、比較的小さな内径を持ち、水に溶けやすい特性があります。β-シクロデキストリンは7つのユニットからなり、最も広く利用されています。内径が適度で、様々な分子を包み込む能力が高いからです。γ-シクロデキストリンは8つのグルコースユニットで構成されており、相対的に大きな疎水性物質を包み込むことができます。この三種類はそれぞれ特有の性質を持ち、用途によって使い分けられています。 シクロデキストリンの主な用途には、食品、医薬品、化粧品、環境技術などがあります。食品分野においては、シクロデキストリンは香料や保存料の安定化に使われ、食品の風味を保つ役割を果たします。また、酸味料や苦味を抑えるためにも使用され、飲料や菓子類において、その特性が活かされています。 医薬品分野では、シクロデキストリンは薬物の溶解性向上や生物学的利用能の改善に寄与しています。特に水に溶けにくい薬剤の包接体を形成することで、薬剤の効果を高めることが可能です。また、シクロデキストリンは薬剤の安定性を向上させ、副作用を軽減する助けにもなります。 化粧品業界でもシクロデキストリンは重要な役割を果たしています。香料や色素の安定化、抗酸化物質の封入などに利用され、肌に優しく、心地よい使用感を提供します。さらに、環境技術においては、有害物質の除去や吸着剤としての利用が期待されています。特に水質浄化や土壌改良において、その特性を活用する研究が進められています。 シクロデキストリンを利用した関連技術には、包接化技術があります。この技術は、物質をシクロデキストリンの中に包み込むことで、物理的および化学的性質を改善します。包接化された物質は、溶解度が向上し、安定性も増すため、多くの応用が見込まれます。 さらに、シクロデキストリンはドラッグデリバリーシステムとしても注目されています。特定の部位に薬剤を効果的に届けるためのキャリアとして機能し、徐放性を持たせることができるため、治療効果を向上させる可能性があります。 また、シクロデキストリンは、利用される際にその生分解性が評価されており、環境にやさしい材料としても注目されています。特に、持続可能な材料やプロセスの開発が進む中で、シクロデキストリンは多くの研究者によって研究対象となっています。 このように、シクロデキストリンは様々な分野での利用が広がっています。今後も新しい用途が考案される可能性があり、さらなる研究と開発が進むことで、その応用範囲はますます広がると期待されています。シクロデキストリンの特性を活かした新たな技術や製品の導入により、私たちの生活や産業に一層の利便性をもたらすことができるでしょう。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
